Home » Topics » Regulatory » Patents

Patents
RSS

Tetra Discovery Partners reports PDE4 inhibitors

April 12, 2016

Gilead Sciences describes TBK1 and IKK-epsilon inhibitors

April 12, 2016

Araxes Pharma discloses RAS inhibitors

April 12, 2016

Bayer Schering Pharma patents coagulation factor XIa and KLKB1 inhibitors

April 12, 2016

MedImmune reports antibodies linked to dimeric pyrrolobenzodiazepine

April 11, 2016

Shifa Biomedical reports endothelial lipase inhibitors

April 11, 2016

Merck & Co. patents prolyl hydroxylase inhibitors

April 11, 2016

Bayer Schering Pharma discloses factor XIa kallikrein B inhibitors

April 11, 2016

FORMA Therapeutics introduces isocitrate dehydrogenase inhibitors

April 8, 2016

Intra-Cellular Therapies discloses PDE1B inhibitors

April 8, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...